About the Firm

A boutique healthcare advisory firm built by an operator.

Operators who do real finance. Not finance people guessing at operations.

Kays Alali is the Managing Partner of MCS Advisory. He leads the firm across all four practice areas, with thirteen-plus years building, financing, and operating private-sector healthcare ventures spanning PE-backed holding companies, family-office investments, multispecialty Ambulatory Surgery Centers, multi-site group healthcare practices, behavioral health platforms, and biotech ventures.

Private-Sector Healthcare Advisory · 2012–Present
  • Non-equity Operating Partner at a healthcare holding company — leading the VC raise plan build (current)
  • Seed-stage VC raise for a behavioral health platform — currently in market
  • Multispecialty ASC physician-investor syndication — structuring a partnership in the Dallas-Fort Worth area (current)
  • Fractional CFO engagements across multispecialty group practices, behavioral health platforms, and biotech ventures
  • Multi-location pain management turnaround: 65-day DSO to 42-day DSO and $3M+ in annual cash flow improvement within six months
  • 12 turnkey Ambulatory Surgery Centers delivered from concept through licensure and accreditation
  • 140,000+ ASC procedures overseen across plastics, pain management, behavioral health, and anesthesia
  • $100M+ in commercial revenue cycles managed
  • $15M+ in client capital secured through VC raises, institutional fundraising, and expansion financing
  • Biotech and healthcare equity research for individual and family-office investors (CatalystIQ)
Military Service · 1989–2012

Retired as Lieutenant Colonel from the US Army Medical Service Corps after 23 years of service and two OIF deployments. Held progressive assignments at tactical and strategic three-star and four-star level commands, including the Office of the Secretary of Defense, Army Medical Command, 5th Army, ARNORTH/NORTHCOM, 3rd Army, Coalition Forces Land Component Command Iraq, and as Senior Military Advisor to the Iraqi Army.

As Ops Officer for JTF CAPMED NCR, led operations in the $1.5B DoD healthcare consolidation that merged three teaching hospitals into one teaching and one community facility, realigned 48 clinics under Joint Task Force reporting to the Secretary of Defense, and ensured continuity of care for 439,000 TRICARE beneficiaries and 9,600 staff.

Earlier, led the U.S. medical delegation at the 2003 Madrid allied conference, sourcing coalition medical capabilities for the Operation Iraqi Freedom coalition strategy with 30 partner nations.

That operating discipline informs how MCS Advisory approaches private-sector M&A integration, multi-site practice consolidation, and capital event preparation — but the firm's center of gravity is its current private-sector practice.

Legion of Merit · Bronze Star · Defense Meritorious Service Medal · Army Meritorious Service Medal · Joint Commendation Medal · Joint Service Achievement Medal · Iraq Campaign Medal · Combat Action Badge · Expert Medical Badge · Order of St. George (peer-nominated, invitation-only membership)

Kays holds an MBA, M.S. in Finance, and M.A. He lives in Tampa, Florida.

Kays Alali presenting a wreath at the Tomb of the Unknown Soldier, Arlington National Cemetery
Arlington National Cemetery · Tomb of the Unknown Soldier
Service

A firm built by an operator who served.

Twenty-three years in the US Army Medical Service Corps. Two OIF deployments. Operations officer on the $1.5B DoD healthcare consolidation in the National Capital Region. Retired Lieutenant Colonel.

MCS Advisory is veteran-owned not as a marketing line, but because the firm's analytical discipline, mission orientation, and respect for the people on the other side of an engagement were built in uniform first.

Client Testimonial

"An extremely dedicated multi-site healthcare executive who knows how to manage P&L, how to drive growth, and how to develop a cohesive and effective team. Expert in healthcare finance. Takes the lead in the M&A process. Returns great value for shareholders. Has my highest recommendation."

Senior Counsel · Corporate & Healthcare Law
Philosophy

Same methodology, four lanes.

MCS Advisory exists at the intersection of operator and finance. The same analytical rigor a senior medical service officer would apply to integrating two hospital systems is the rigor we apply to a biotech sum-of-parts thesis, a multispecialty ASC physician-investor syndication, or a behavioral health VC raise plan.

DCF, rNPV, sum-of-parts, M&A reverse-engineering — calibrated against actual closed transactions, not theoretical frameworks.

Across every engagement: data over gut. Precision over guesswork.

What We Believe

Three pillars.

FAITH

We operate from a foundation of conviction. Hebrews 11:1 — the assurance of things hoped for, the conviction of things not seen — describes both our personal anchor and the analytical work we do: valuing what is not yet visible.

SERVICE

A career of service shapes how we work. Every engagement is a duty to the client's mission, not a transaction. We answer the phone, we do the work, and we stay in the foxhole until the deal is done.

PRECISION

The military taught us that precision, discipline, and decisive action are not optional. They are the difference between organizations that survive and those that thrive. Same discipline applies to a five-year proforma, a cap table, or a DCF.

Who We Work With

The clients across our four lanes.

PE-backed healthcare platforms & holding companies
Capital strategy, multi-site integration, operating partner work, exit preparation
Family offices investing in healthcare and biotech
Due diligence, investment analysis, position monitoring, deal sourcing
Multispecialty Ambulatory Surgery Centers
Syndication structuring, development, fractional CFO, capital events
Multi-site group healthcare practices
Growth strategy, FP&A, MSO structuring, capital raises
Behavioral health platforms & biotech founders
VC raises (seed through Series B), institutional fundraising, board reporting
Defense-tech medical & dual-use medical ventures
Capital advisory, federal market strategy, DHA-adjacent positioning
Individual investors using CatalystIQ
Institutional-grade biotech and macro analysis, productized for retail
Let's talk

Confidential conversations.

Every initial conversation is with Kays directly. We evaluate engagements on fit, mandate, and the specific work to be done.

Request a confidential conversation